Skip to main content
OpenTrials

Clinical trial condition

Metastatic Non-small Cell Lung Cancer

Explore clinical trials studying Metastatic Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

37 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Non-small Cell Lung Cancer trial results

Completed

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

NCT03679767

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Fresno, California, United States
  • California Cancer Associates for Research and Excellence Fresno, California, United States
  • California Cancer Associates for Research and Excellence, Inc. San Marcos, California, United States
  • St Joseph Heritage Healthcare Santa Rosa, California, United States
View all 52 locations
View Trial Details
Completed

A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer

NCT02857270

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View all 13 locations
View Trial Details
Completed

Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC

NCT03164772

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Research Facility Gilbert, Arizona, United States
  • Research Facility Tampa, Florida, United States
  • Research Facility Detroit, Michigan, United States
  • Research Facility New York, United States
View Trial Details
Completed

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

NCT00806286

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Colorado Cancer Center Aurora, Colorado, United States
  • Georgetown Univ. Medical Center Washington D.C., District of Columbia, United States
  • Southern Illinois Hematology/Oncology Centralia, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 28 locations
View Trial Details
Completed

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT01395758

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Stanford, California, United States
  • Washington D.C., District of Columbia, United States
  • Weston, Florida, United States
  • Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

NCT05984277

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Springdale, Arkansas, United States
  • Research Site Long Beach, California, United States
  • Research Site Lone Tree, Colorado, United States
View all 247 locations
View Trial Details
Active, Not Recruiting

Plasma-Adapted First-Line Pembro In NSCLC

NCT04166487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States
View Trial Details

Related conditions